Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Evaluation of Immunologic Response following COVID-19 Vaccination in Children, Adolescents, and Young Adults with Cancer

This study evaluates immunologic response following COVID-19 vaccination in children, adolescents, and young adults with cancer. Vaccines work by stimulating the bodys immune cells to respond against a specific disease. The immune response produces protection from that disease. Effects from cancer and from treatments for cancer can reduce the bodys natural disease fighting ability (called immunity). Factors such as vaccine type, timing of vaccine dosing related to treatment for cancer and number of vaccine doses or boosts (extra vaccine shots) may strengthen or diminish the bodys protective immune response. This study may help researchers learn more about how the bodys immune system responds to the COVID-19 vaccine when the vaccination is given during or after cancer treatment.
Pediatrics
N/A
Both
Not Available
Not Available
Esbenshade, Adam
International
Vanderbilt University
02-17-2023
Other
COGACCL21C2
NCT05228275

Eligibility

6 Months
BOTH
NO

To learn more about any of our clinical
trials, call 615-936-8422.